Revenue came to $39 billion for the fiscal quarter ended in November, driven by higher prices for branded drugs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback